Larry Lawson is a Founder and Executive Chairman at Proxima. He has 45+ years of experience in the healthcare industry.
He has been the founder, board member, and executive at several medical device companies: eCardio Diagnostics, Decisio Health, HeartcoR Solutions, and Preventice. He is an Angel Investor with the Goose Society, TMC Venture Fund, and Angel MD.
He is a Distinguished American Award recipient from the Horatio Alger Association.
Kevin Coker is a Co-Founder and the Chief Executive Officer at Proxima. He has 20+ years of experience in the healthcare industry.
He has been the founder, board member, and executive at several life science companies: Worldwide Clinical Trials, McKesson Corporation, and US Oncology.
Kevin is an attorney and is certified in regulatory affairs. He has worked with hundreds of pharmaceutical, biotech, and life science companies.
Dr. Jaye Thompson is a Co-Founder and the Chief Operating Officer at Proxima. She has 25+ years of experience in the healthcare industry.
She is an entrepreneur and has been an executive at several biotech companies: Synergos Inc (Founder, acquired by inVentiv Health), Opexa Therapeutics, and Repros Therapeutics.
Jaye is a biostatistician with clinical trial and regulatory expertise and has a history of assisting emerging companies meet their milestones.
Matt received his Biomedical Sciences degree from Texas A&M University and has over 15 years of industry experience working across multiple life science businesses in critical areas, including clinical operations, business operations, and business development. He also has experience in the lung, GI, hematology, orthopedic surgery, and radiation oncology research programs.
Alisa graduated from Stephen F. Austin State University with a B.B.A in May of 2016, where she was a 4-year letterman scholarship-athlete. She has over eight years of business management experience. Previous to Proxima, she was a customer relations specialist at Baylor Scott and White.
Prior to joining Proxima, Isabella served as the Senior Regulatory & Quality Manager at a medical device company, where she outlined the regulatory strategy & put together design controls & design history documentation. She was the Dir. of CMC & Quality at a biopharmaceutical company, where she oversaw all manufacturing and analytical processes and timelines and ensured CMC regulatory strategy was sufficient for filings in Europe and the US.
Mr. Lewis holds a B.S. in Mathematics and an M.S. in statistics from Stephen F. Austin State University and a Ph.D. candidate in Biostatistics from the University of Texas Health Science Center in Houston. Through his 15 years of experience, he has advised many life science companies on statistical methodologies, regulatory affairs, and clinical product development, and has represented clients at the FDA.
Melissa has over five years of experience in Data Management and has also worked in computer system validation for both EDC systems and electronic signatures. She has also gained experience in SAS programming with both statistical analyses and data manipulation.
Nwabufo obtained his B.Sc. in Biotechnology with a minor in Business Administration from the Richard Stockton University, New Jersey. Nwabufo has over four years of global experience in a variety of therapeutic areas, including cardiovascular, oncology, ophthalmology, infectious diseases, CNS, and metabolic diseases as a clinical research associate.
Taylor Lunsford is a Regulatory Affairs Associate from Houston, Texas and holds degrees from the University of Houston and the Defense Language Institute. Before working with Proxima, he served in the Army as a Mandarin Chinese translator and intelligence analyst.
Andrew Frink is from Dallas, TX, and is a Regulatory Specialist for Proxima. Andrew enjoys learning about emerging technologies, but is particularly interested in gene therapy immunotherapy, and diagnostics. When he is not working, he enjoys hiking and bike riding with his family.
Ken Fujiwara received his B.S. in Biology from Duke University; a Ph.D in Integrative Molecular and Biomedical Sciences from Baylor College of Medicine. He has an extensive bench science background in biomedical research labs during his graduate career at BCM, and also as a research technician at the Duke University Center for Human Genetics and the Duke Institute for Genome Sciences and Policy.
Ellie Reynolds is from Dallas, Texas and is a Quality Assurance and Regulatory Affairs Associate for Proxima. She just completed her M.B.E. in Bioengineering at Rice University and previously received her B.E. in Biomedical Engineering from Vanderbilt University. Prior to completing her master's degree, she worked in strategy consulting for biotech and pharma companies and is eager to combine her educational background and professional experience in this role.
Jenna has been monitoring clinical trials for over 4 years for both CRO and sponsor companies. She graduated with a B.S. in Biology from North Park University in Chicago, IL and has completed a postgraduate course in Microbiology at James Cook University in Australia.
Prior to joining Proxima, Nicole received her B.S Biomedical Sciences from Texas A&M University. She has completed several internships in the fields of psychology, genetics, clinical dermatology, and pharmaceutical sciences. Nicole is also a graduate student at UNC Chapel Hill working on a Master of Professional Science in Biomedical and Health Informatics.
Syd Wiggins is a Regulatory Affairs Associate from The Natural State who holds a B.S. and M.S. in Biomedical Engineering from the University of Arkansas and the University of Florida, respectively. Her research experience includes cancer biology and the development of biomaterials for localized drug delivery.
Aryan received his B.S. in Biomedical Engineering from Texas A&M University. He has experience in Design and Development, Quality Control, and Quality Assurance and is particularly interested in the use of biomaterials and production of cost-effective medical devices to improve quality of life for patients from various socioeconomics background.